Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its…
Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump in the third quarter. The company, which has business lines…
Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test uses…